Centurion Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Sell
6,244
-957
-13% -$223K 0.38% 63
2026
Q1
$1.76M Sell
7,201
-32
-0.4% -$7.45K 0.4% 65
2025
Q4
$1.5M Sell
7,233
-109
-1% -$21.6K 0.33% 69
2025
Q3
$1.36M Buy
7,342
+1,816
+33% +$311K 0.31% 73
2025
Q2
$844K Buy
5,526
+416
+8% +$63.9K 0.24% 76
2025
Q1
$739K Hold
5,110
0.23% 76
2024
Q4
$739K Sell
5,110
-176
-3% -$27.3K 0.23% 76
2024
Q3
$857K Buy
+5,286
New +$842K 0.27% 70
2024
Q1
$921K Buy
5,823
+5
+0.1% +$796 0.36% 55
2023
Q4
$912K Sell
5,818
-387
-6% -$59.3K 0.39% 49
2023
Q3
$966K Sell
6,205
-604
-9% -$99.7K 0.47% 47
2023
Q2
$1.13M Buy
6,809
+387
+6% +$62.5K 0.54% 41
2023
Q1
$995K Sell
6,422
-63
-1% -$10.2K 0.5% 45
2022
Q4
$1.15M Buy
+6,485
New +$1.12M 0.65% 38

Other funds holding JNJ

Centurion Wealth Management's JNJ Position: Q2 2026 in Review

Centurion Wealth Management reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $223K and leaving 6,244 shares worth $1.59M. The position accounts for 0.38% of the portfolio, ranked #63.

Centurion Wealth Management first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.76M in Q1 2026. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Centurion Wealth Management held 6,244 shares of Johnson & Johnson worth $1.59M as of Q2 2026.
  • Centurion Wealth Management sold 957 Johnson & Johnson shares in Q2 2026, an estimated $223K.
  • Johnson & Johnson made up 0.38% of Centurion Wealth Management's portfolio in Q2 2026, its #63 holding.
  • Centurion Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • Centurion Wealth Management's Johnson & Johnson position peaked at $1.76M in Q1 2026.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.